Pictet Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$89.8M Sell
1,147,659
-83,154
-7% -$6.71M 0.09% 245
2026
Q1
$107M Sell
1,230,813
-79,699
-6% -$7.64M 0.11% 205
2025
Q4
$126M Sell
1,310,512
-20,091
-2% -$1.95M 0.12% 188
2025
Q3
$127M Buy
1,330,603
+181,230
+16% +$16.7M 0.12% 188
2025
Q2
$100M Buy
1,149,373
+111,696
+11% +$9.47M 0.1% 206
2025
Q1
$93.2M Buy
1,037,677
+92,617
+10% +$8.29M 0.1% 212
2024
Q4
$75.5M Buy
945,060
+62,853
+7% +$5.44M 0.08% 241
2024
Q3
$79.4M Buy
882,207
+255,851
+41% +$21.5M 0.09% 232
2024
Q2
$49.3M Buy
626,356
+12,752
+2% +$1.05M 0.06% 286
2024
Q1
$53.5M Buy
613,604
+3,801
+0.6% +$324K 0.06% 297
2023
Q4
$50.2M Buy
609,803
+437
+0.1% +$33.3K 0.06% 308
2023
Q3
$47.7M Buy
+609,366
New +$51M 0.06% 290

Other funds holding MDT

Pictet Asset Management's MDT Position: Q2 2026 in Review

Pictet Asset Management reduced its Medtronic (MDT) stake by 6.8% in Q2 2026, selling an estimated $6.71M and leaving 1,147,659 shares worth $89.8M. The position accounts for 0.09% of the portfolio, ranked #245.

Pictet Asset Management first reported a position in MDT in Q3 2023 and has held it in 12 quarters since. The position peaked at $127M in Q3 2025. 2,123 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Pictet Asset Management held 1,147,659 shares of Medtronic worth $89.8M as of Q2 2026.
  • Pictet Asset Management sold 83,154 Medtronic shares in Q2 2026, an estimated $6.71M.
  • Medtronic made up 0.09% of Pictet Asset Management's portfolio in Q2 2026, its #245 holding.
  • Pictet Asset Management first reported a position in Medtronic in Q3 2023 and has held it in 12 quarters since.
  • Pictet Asset Management's Medtronic position peaked at $127M in Q3 2025.
  • 2,123 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.